Return to Article Details CLINICAL AND CARDIOMETABOLIC EFFICACY OF FRUCTOSE-1,6-DIPHOSPHATE (NEOSTIN) THERAPY IN PATIENTS WITH COMORBID CARDIOVASCULAR DISEASES AND TYPE 2 DIABETES MELLITUS